National Bank of Canada
EW icon

National Bank of Canada’s Edwards Lifesciences EW Stock Holding History

National Bank of Canada’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.3M Sell
303,249
-19,710
-6% -$1.62M 0.02% 443
2025
Q4 		$27.5M Sell
322,959
-47,455
-13% -$3.89M 0.03% 443
2025
Q3 		$28.8M Sell
370,414
-88,239
-19% -$6.89M 0.03% 403
2025
Q2 		$35.9M Sell
458,653
-82,878
-15% -$6.18M 0.03% 374
2025
Q1 		$39.2M Buy
541,531
+209,144
+63% +$15M 0.04% 357
2024
Q4 		$24.6M Buy
332,387
+28,534
+9% +$2M 0.03% 503
2024
Q3 		$20.1M Buy
303,853
+65,982
+28% +$4.79M 0.02% 482
2024
Q2 		$21.5M Buy
237,871
+34,635
+17% +$3.07M 0.03% 373
2024
Q1 		$17.6M Sell
203,236
-11,625
-5% -$977K 0.03% 453
2023
Q4 		$16.2M Buy
214,861
+9,352
+5% +$651K 0.03% 457
2023
Q3 		$14.2M Buy
205,509
+33,350
+19% +$2.68M 0.02% 505
2023
Q2 		$15.8M Buy
172,159
+77,698
+82% +$6.75M 0.03% 422
2023
Q1 		$7.79M Buy
94,461
+53,633
+131% +$4.22M 0.02% 483
2022
Q4 		$3.05M Sell
40,828
-12,565
-24% -$968K 0.01% 766
2022
Q3 		$4.41M Buy
53,393
+34,177
+178% +$3.29M 0.02% 561
2022
Q2 		$1.83M Sell
19,216
-2,585
-12% -$268K 0.01% 810
2022
Q1 		$2.57M Sell
21,801
-8,439
-28% -$947K 0.01% 804
2021
Q4 		$3.9M Buy
+30,240
New +$3.53M 0.01% 625

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

National Bank of Canada's EW Position: Q1 2026 in Review

National Bank of Canada reduced its Edwards Lifesciences (EW) stake by 6.1% in Q1 2026, selling an estimated $1.62M and leaving 303,249 shares worth $24.3M. The position accounts for 0.02% of the portfolio, ranked #443.

National Bank of Canada first reported a position in EW in Q4 2021 and has held it in 18 quarters since. The position peaked at $39.2M in Q1 2025. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • National Bank of Canada held 303,249 shares of Edwards Lifesciences worth $24.3M as of Q1 2026.
  • National Bank of Canada sold 19,710 Edwards Lifesciences shares in Q1 2026, an estimated $1.62M.
  • Edwards Lifesciences made up 0.02% of National Bank of Canada's portfolio in Q1 2026, its #443 holding.
  • National Bank of Canada first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 18 quarters since.
  • National Bank of Canada's Edwards Lifesciences position peaked at $39.2M in Q1 2025.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.